학술논문

Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia

Document Type

Report

Author

Giagounidis, Aristoteles; Mufti, Ghulam J.; Fenaux, Pierre; Sekeres, Mikkael A.; Szer, Jeffrey; Platzbecker, Uwe; Kuendgen, Andrea; Gaidano, Gianluca; Wiktor-Jedrzejczak, Wieslaw; Kuolung Hu; Woodard, Paul; Yang, Allen S.; Kantarjian, Hagop M.

Source

Cancer. June 15, 2014, Vol. 120 Issue 12, p1838, 9 p.

Subject

Dosage and administration
Research
Risk factors
Usage
Romiplostim -- Dosage and administration
Romiplostim -- Research
Myelodysplastic syndromes -- Risk factors
Thrombocytopenia -- Risk factors
Clinical trials -- Usage

Language

English

ISSN

0008-543X

Online Access

Full Text (Wiley Journals) Full Text (Wiley-DB) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송